The latest market report published by Credence Research, Inc. “Global Hemodialysis and Peritoneal Dialysis Market By Type (Hemodialysis, Peritoneal Dialysis), By Product (Services, Devices, Consumables) – Growth, Future Prospects, Competitive Analysis, 2018 – 2026,” The worldwide market for hemodialysis and peritoneal dialysis is estimated at US$ 63,796.2 million and is anticipated to reach US$ 1,09,625.8 million by 2026 with a 6.2 per cent increase in CAGR from 2018 to 2026.
According to the World Health Organization (WHO), the worldwide incidence rate for chronic kidney disease ranges from 11 to 13 per cent with the majority of patients in phase 3 of renal disease. Lack of early medical intervention and frequent renal transplant failure has resulted to an increase in mortality due to chronic kidney disease. Hemodialysis and peritoneal dialysis is presently the best feasible therapy choice for patients with end-stage renal disease.
Browse the full report at https://www.credenceresearch.com/report/hemodialysis-and-peritoneal-dialysis-market
Hemodialysis dominates the industry for hemodialysis and peritoneal dialysis. Rising popularity of the nocturnal hemodialysis operation and a steady increase in the amount of renal transplant mistakes in patients with end-stage renal cancer are driving the market for hemodialysis. Peritoneal dialysis is gaining traction due to low price, low infection rate and improved patient compliance compared to hemodialysis.
Services are the product segment of the market for hemodialysis and peritoneal dialysis. The rapid growth in the amount of clinics and the accessibility of qualified medical experts specializing in kidney dialysis are driving market growth in healthcare. Supportive regulatory environment and sophisticated characteristics that demonstrate ease of operation and patient compliance would eventually lead in rapid device development. Consumables are in high demand owing to their disposable nature and lower risk of infection during dialysis 2 to 3 times a week.
North America is currently a clear leader in the regional sector for hemodialysis and peritoneal dialysis. Rampant development in hospitals and clinics linked to kidney care and increasing incidence of end-stage renal disease in the elderly is driving market growth in North America. Europe is motivated by variables such as inexpensive reimbursement for patients receiving dialysis in hospital environments and the home of main players such as DaVita, Inc., Cantel Medical Corporation, Medline Industries, Inc., etc. Asia Pacific is set to record remarkable development during the forecast period due to variables such as the increasing incidence of chronic kidney disease and the completion by local players of market leaders resulting in favorable hemodialysis traction and market growth in peritoneal dialysis.
Medical device manufacturers providing services, devices and consumables pertaining to hemodialysis and peritoneal dialysis are Asahi Kasei Corporation, Baxter International, Cantel Medical Corporation, DaVita, Inc., Dialysis Clinic, Inc., Fresenius Medical Care AG & Co., KGaA, Medline Industries, Inc., Merit Medical Systems, Nipro Medical Corporation and NxStage Medical, Inc.
Download Free PDF Sample Request: https://www.credenceresearch.com/sample-request/59491
Key Market Movements:
- Rising prevalence of chronic kidney disease throughout the globe
- Increasing demand for hemodialysis and peritoneal dialysis in comparison to kidney transplant in patients suffering with end stage renal disease
- Affordable reimbursement scenario for dialysis performed by in bound patients in hospital settings.
Report Scope by Segments
By Type (2016–2026; US$ Mn)
- Short Daily
- Peritoneal Dialysis
- Continuous Ambulatory Peritoneal Dialysis (CAPD)
- Automated Peritoneal Dialysis (APD)
By Product (2016–2026; US$ Mn)
By Geography Segment (2016–2026; US$ Mn)
- North America
- Asia Pacific (APAC)
- Middle East & Africa (MEA)
- Latin America